Artificial Intelligence In Healthcare Market - India

Market Statistics

• Base Year: 2024

• Historical Years: 2019-2024

• Forecast Years: 2025-2033

• Market Size in 2024: USD 333.16 Million

• Market Size in 2033: USD 4,165.26 Million

• Market Growth Rate (CAGR) 2025-2033: 30.78%

According to IMARC Group's report titled "India Artificial Intelligence In Healthcare Market Report and Forecast 2025-2033," the market reached USD 333.16 million in 2024. Looking forward, IMARC Group expects the market to reach USD 4,165.26 million by 2033, exhibiting a growth rate (CAGR) of 30.78% during 2025-2033.

Download sample copy of the Report: https://www.imarcgroup.com/india-artificial-intelligence-in-healthcare-market/requestsample

India Artificial Intelligence In Healthcare Market Trends and Drivers:

1. India artificial intelligence in healthcare market is being dynamically stimulated by heightened digitalization in the healthcare industry, growing volumes of patient data, and requirements for enhanced diagnostic and operational efficacy.

2. Essentially, with healthcare providers experiencing the double challenge of controlling large-scale health needs and containing costs, AI-based solutions are being effective in optimizing clinical outcomes, hospital workflows, and real-time decision-making support.

3. Furthermore, the increasing prevalence of chronic ailments like diabetes, cardiovascular diseases, and cancer is propelling the demand for AI-based predictive analytics, timely diagnosis, and customized treatment protocols.

4. Additionally, increased adoption of electronic health records (EHRs), telemedicine platforms, and mobile health apps is generating massive data lakes, which are powering AI solutions to population health management and virtual care platforms.

5. In addition to this, India's strong startup ecosystem, supported by venture capital funding and supportive policy initiatives such as the National Digital Health Mission, is driving innovation in AI-based healthcare products and services.

6. Further, AI-powered imaging and diagnostic platforms are picking up in radiology, pathology, and ophthalmology, providing faster and more accurate image interpretation compared to conventional approaches.

7. Furthermore, natural language processing (NLP) and machine learning (ML) technologies are increasingly being utilized for the automation of medical transcription, clinical documentation, and patient engagement systems.

8. Moreover, the growth in wearable devices and remote health monitoring devices is facilitating preventive care and disease management of chronic diseases by way of AI-powered alerts and ongoing health data analysis.

9. Besides this, hospital executives are implementing AI-driven solutions for resource optimization, patient wait-time reduction, and enhanced supply chain operations.

10. Additionally, AI-powered chatbots and virtual health assistants are being implemented to provide 24/7 patient care, health inquiries, and medicine reminders, particularly in tier 2 and tier 3 cities.

11. Also, partnerships between health professionals, technology firms, and research organizations are driving R&D in drug discovery, genomics, and personalized medicine with AI.

12. Finally, the government's initiative for digital health innovation and data standardization is motivating the safe and secure adoption of AI in clinical environments.

13. As a whole, the intersection of cutting-edge technologies, heightened health consciousness, favorable policy environment, and pressing healthcare needs is placing artificial intelligence in the role of an industry-transformative force in India's shifting healthcare landscape.

India Artificial Intelligence In Healthcare Industry and Segmentation:

The report has segmented the market into the following categories:

Analysis by Offering:

• Hardware

• Software

• Services

Analysis by Technology:

• Machine Learning

• Context-Aware Computing

• Natural Language Processing

• Others

Analysis by Application:

• Robot-Assisted Surgery

• Virtual Nursing Assistant

• Administrative Workflow Assistance

• Fraud Detection

• Dosage Error Reduction

• Clinical Trial Participant Identifier

• Preliminary Diagnosis

• Others

Analysis by End User:

• Healthcare Providers

• Pharmaceutical and Biotechnology Companies

• Patients

• Others

Regional Analysis:

• North India

• West and Central India

• South India

• East and Northeast India

Request for customization: https://www.imarcgroup.com/request?type=report&id=21830&flag=C

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key highlights of the Report:

• Market Performance (2019-2024)

• Market Outlook (2025-2033)

• COVID-19 Impact on the Market

• Porter’s Five Forces Analysis

• Strategic Recommendations

• Historical, Current and Future Market Trends

• Market Drivers and Success Factors

• SWOT Analysis

• Structure of the Market

• Value Chain Analysis

• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: sales@imarcgroup.com 

Tel No:(D) +91 120 433 0800 

United States: +1-201971-6302